Identification
- Composition (DCI)
- lévonorgestrelethinylestradiol
- Manufacturer
- BAYER S.A
- ATC code
- G03AA07
- Presentation
- Boîte de 21
- Schedule / Reimb.
- A
- Hospital price
- 5.10 MAD
Indications
Contraception hormonale orale en tenant compte des facteurs de risque de la patiente, notamment ses facteurs de risque de thrombo-embolie veineuse (TEV), ainsi que du risque de TEV associé à Microgynon en comparaison aux autres CHC (Contraceptifs Hormonaux Combinés).
Find an open pharmacy
On-call pharmacies near you
About MICROGYNON 0.15 MG / 0.03 MG
MICROGYNON 0.15 MG / 0.03 MG is marketed in Morocco by BAYER S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of MICROGYNON 0.15 MG / 0.03 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about MICROGYNON 0.15 MG / 0.03 MG
Answers to common questions from Moroccan patients about this drug.